EUVIMEDEUVIMED entdecken
Crossref

Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease

Foteini Theodorakakou iD, Alexandros Briasoulis, Despina Fotiou, Ioannis Petropoulos, Georgios Georgiopoulos, Niki Lama, Nikolaos Kelekis, Evangelos Repasos, Magdalini Migkou, Kimon Stamatelopoulos, Meletios A Dimopoulos, Efstathios Kastritis

Hematological Oncology · 2023

DOI: 10.1002/hon.3135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2023. Verfasst von Foteini Theodorakakou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis, Amyloidosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with cardiac light chain amyloidosis and Mayo stage 3b disease define a high‐risk population with very poor prognosis. Here, we report treatment outcomes of 80 consecutive patients with newly diagnosed AL and Mayo 3b who received novel regimens. Early mortality (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin Light-chain AmyloidosisAmyloidosisHumansTreatment OutcomePrognosisImmunoglobulin kappa-ChainsRetrospective Studies

Stichwörter der Autor:innen

NTproBNPcardiac amyloidosisfree light chainsmayo stage

Substanzen

Immunoglobulin kappa-Chains

Autor:innen und Institutionen

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • 2nd Department of Radiology, Research Unit of Radiology and Medical Imaging, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

ORCID-Profile: Foteini Theodorakakou

Zitieren

APA

Theodorakakou, F., Briasoulis, A., Fotiou, D., Petropoulos, I., Georgiopoulos, G., Lama, N., Kelekis, N., Repasos, E., Migkou, M., Stamatelopoulos, K., Dimopoulos, M. A., & Kastritis, E. (2023). Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease. Hematological Oncology. https://doi.org/10.1002/hon.3135

Vancouver

Theodorakakou F, Briasoulis A, Fotiou D, Petropoulos I, Georgiopoulos G, Lama N, et al. Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease. Hematological Oncology. 2023. doi:10.1002/hon.3135

BibTeX
@article{Theodorakakou2023,
  author = {Theodorakakou, Foteini and Briasoulis, Alexandros and Fotiou, Despina and Petropoulos, Ioannis and Georgiopoulos, Georgios and Lama, Niki and Kelekis, Nikolaos and Repasos, Evangelos and Migkou, Magdalini and Stamatelopoulos, Kimon and Dimopoulos, Meletios A and Kastritis, Efstathios},
  title = {Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease},
  journal = {Hematological Oncology},
  year = {2023},
  doi = {10.1002/hon.3135}
}
Kostenlos starten →